N-Acetyl-L-Leucine for GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease)
Clinical trial NCT03759665 · COMPLETED
Trial details
- NCT number
- NCT03759665
- Sponsor
- IntraBio Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-07
- Primary completion
- 2023-01-09
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.